IRIS
MONDELLI, MARIO UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.696
EU - Europa 4.800
AS - Asia 3.414
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 6
SA - Sud America 2
Totale 14.939
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.622
CN - Cina 2.965
IE - Irlanda 1.377
UA - Ucraina 865
FI - Finlandia 654
DE - Germania 583
IT - Italia 533
SE - Svezia 360
SG - Singapore 357
GB - Regno Unito 215
FR - Francia 129
CA - Canada 70
IN - India 26
VN - Vietnam 22
JP - Giappone 19
BE - Belgio 17
NL - Olanda 15
CZ - Repubblica Ceca 14
RU - Federazione Russa 14
IR - Iran 13
AU - Australia 10
CH - Svizzera 6
EU - Europa 6
HK - Hong Kong 6
LT - Lituania 4
MU - Mauritius 4
A2 - ???statistics.table.value.countryCode.A2??? 3
ES - Italia 3
LU - Lussemburgo 3
MX - Messico 3
GR - Grecia 2
ID - Indonesia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
AR - Argentina 1
AT - Austria 1
CR - Costa Rica 1
DK - Danimarca 1
EG - Egitto 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
NP - Nepal 1
RS - Serbia 1
TR - Turchia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 14.939
Salva come PNG Salva come JPEG
Città #
Chandler 1.432
Dublin 1.373
Jacksonville 1.191
Nanjing 902
Ashburn 694
Boardman 471
Nanchang 380
Princeton 321
Lawrence 288
Wilmington 271
Shenyang 251
Singapore 239
Hebei 237
Changsha 219
Jiaxing 219
Helsinki 169
Beijing 163
Tianjin 163
Medford 158
Milan 151
Hangzhou 138
Ann Arbor 99
Shanghai 85
Verona 68
New York 65
Woodbridge 60
Pavia 59
Norwalk 56
Toronto 56
Munich 41
Seattle 41
Fairfield 26
Los Angeles 26
Des Moines 25
Dong Ket 22
Jinan 22
Falls Church 20
Zhengzhou 20
Auburn Hills 19
Kunming 18
Brussels 17
Tokyo 17
Pune 15
Piscataway 14
Washington 14
Berlin 13
Guangzhou 13
Ningbo 13
Trieste 13
Bergamo 12
Chicago 12
Dearborn 12
London 12
Vicenza 11
Brno 9
Houston 9
Taizhou 9
Lodi 8
San Jose 8
Falkenstein 7
Cambridge 6
Changchun 6
Como 6
Modena 6
Rome 6
Travaco Siccomario 6
Borås 5
Florence 5
Gunzenhausen 5
Monza 5
Naples 5
Orange 5
Zanjan 5
Carbonara al Ticino 4
Cork 4
Dresden 4
Hefei 4
Hong Kong 4
Lanzhou 4
Leawood 4
Motta Visconti 4
Novokuznetsk 4
Serra 4
Taiyuan 4
Andover 3
Catania 3
Costa Mesa 3
Dallas 3
Ferrara di Monte Baldo 3
Fuzhou 3
Magenta 3
Olomouc 3
Ottawa 3
Padova 3
Paris 3
Saluzzo 3
Santa Clara 3
Sydney 3
Tijuana 3
Turin 3
Totale 10.659
Salva come PNG Salva come JPEG
Nome #
MICA/B-targeted antibody promotes NK cell-driven tumor immunity in patients with intrahepatic cholangiocarcinoma 251
Mapping the human genetic architecture of COVID-19 162
Mapping the human genetic architecture of COVID-19 93
A first update on mapping the human genetic architecture of COVID-19 92
Cross-reactive antibodies to hypervariable region 1 (HVR1) of the hepatitis C virus E2/gp70 glycoprotein 88
Hepatitis B virus structure and biology. 87
Does the immune response play a role in the pathogenesis of chronic liver disease? 84
GB virus C infection in patients treated for childhood acute lymphoblastic leukemia 78
Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation 75
NKG2D and its ligands: key to immunotherapy of liver cancer? 74
Recombinant human antibodies specific for hepatitis C virus proteins 74
Detection of HTLV-III specific IgG in the CSF from patient with AIDS and encephalitis. 73
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 73
Acute hepatitis C: diagnosis and management. 72
ANTIBODY RESPONSES TO HEPATITIS C VIRUS HYPERVARIABLE REGION 1: EVIDENCE FOR CROSS-REACTIVITY AND IMMUNE-MEDIATED SEQUENCE VARIATION. 71
Codon 72 polymorphisms of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients 70
Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. 70
Detection of genomic and minus strand C virus RNA in the liver of chronic hepatitis C patients by strand-specific semi-quantitative RT-PCR 70
Molecular epidemiology of hepatitis C virus infection in intravenous drug users. 68
Antibody responses to the hepatitis C virus (HCV) E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects. 68
Characterization of monoclonal antibodies (mAb) from mice immunized with HCV hypervariable region 1 (HVR1) mimotopes. 68
Lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection. 68
A major conformational B cell epitope on the HCV NS3 region defined by a human monoclonal antibody 68
PD-L1 negatively regulates CD4+CD25+Foxp3+ tregs by limiting STAT-5 phosphrylation in patients chronically infected with HCV 68
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 68
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. 67
Clonality and specificity of cryoglobulins associated with HCV: pathophysiological implications 67
B lymphocyte activation in chronic HCV infection: implications for autoimmune and lymphoproliferative disorders 67
EASL Clinical Practice Guidelines: management of hepatitis C virus infection 67
Clinical significance of hepatitis C virus genotypes. 66
Cytotoxic T cell in chronic non-A, non-B hepatitis 66
Antibody-negative chronic hepatitis C virus infection in immunocompetent children 66
A human monoclonal antibody specific for a conserved epitope within the HCV protein 66
The impact of viral genotype on the natural history of HCV-induced cirrhosis: a prospective study 66
Is the natural history of hepatitis C virus carriers with normal aminotransferase really bening? 65
A survey of hepatitis C virus infection in haemodialysis patients over a 7-years follow-up. 65
Enhanced NK cytolytic activity in chronic HCV infection 65
Mutations at position 385 within the hypervariable region 1 (HVR1) of the hepatitis C virus (HCV) are rare and not rescricted to patients with cryoglobulinemia 64
Characterization of cryoglobulins from patients with type II mixed cryoglobulinaemia associated with HCV 64
Relationship between expression of HBV antigenes in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic HBV infection. 64
A human monoclonal antibody specific for the N-terminus of hepatitis C virus nucleocapsid protein 64
Identification of HCV core mimotopes: improved methods for the selection and use of diasease-related phage-displayed peptides 64
Autoimmune hepatitis in children and hepatitis C virus testing 64
Mimotopes of the hypervariable region 1 of the hepatits C virus induce cross-reactive antibodies directed against discontinuous epitopes 63
Monitoring response to antiviral therapy in patients with chronic hepatitis C virus infection by a core antigen assay. 63
High prevalence of antibodies to hepatitis C virus in haemodialysis units using a 2nd generation assay 63
HLA class II alleles confer protection or susceptibility to chronic hepatitis C 63
Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C 63
Low prevalence of antibodies to the HCV envelope region in anti-HCV seronegative, HCV RNA positive patients 63
Immunophatological aspects of liver cell injury in chronic hepatitis B virus infection 63
Defective cytotoxic function of intrahepatic natural killer cells in chronic hepatitis C virus infection 63
CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. 63
Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in haemodialysis patients. 63
Adenoviral mediated expression of anti-HCV NS3 single-chain Fv (sFv) antibody reduces HCV RNA in infected hepatocytes 63
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 63
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 63
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 62
Natural killer activity in acute viral hepatitis 62
Alfa-interferon enhances non-T cell cytotoxicity fo rautologous hepatocytes in acute and chronic HBV infection 62
Optimization for the detection of hepatitis C virus (HCV) antigens in the liver 62
HCV viremia in hemodialysis patients 62
Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes 62
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. 61
Occult hepatitis B virus infection 61
Lymphocyte cytotoxycity to autologous hepatotytes in alfa1-antitrypsin deficiency. 61
Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T-cell lines 61
Absence of antibodies to human immunodeficiency virus in long-term institutionalized psychiatric patients. 61
Who is more likely to respond to dual treatment with PEG-interferon and ribavirin for chronic hepatitis c? A gender-oriented analysis 61
SIGNIFICANCE OF THE IMMUNE RESPONSE TO A MAJOR, CONFORMATIONAL B CELL EPITOPE ON THE HEPATITIS C VIRUS NS3 REGION DEFINED BY A HUMAN MONOCLONAL ANTIBODY 61
HCV genotype 1b is a major risk factor for the development of hepatocellular carcinoma (HCC) in cirrhotic patients: a prospective study 61
Insulin resistance is associated with steatosis in non-diabetic patients with genotype 1 chronic hepatitis C 60
Assessment of HCV RNA clearance under combination therapy for HCV genotype 1: performance of the transcription-mediated amplification (TMA) assay. 60
Subversion of CD8+ T cell differentiation in acute hepatitis C virus infection: the role of the virus. 60
Interferon-alpha enhances non-specific cytotoxicity for autologous hepatocytes in acute and chronic hepatitis B virus infection 60
Hepatitis C is more severe in drug users with human immunodeficiency virus infection 60
Epidemiology of HCV genotypes and risk of cirrhosis in apulia: a population-based case-control study 60
Humoral immunity against the hypervariable regione 1 of the putative envelope glycoprotein (Gp70) in hepatitis C patients 60
NK cell phenotype and function are profoundly different in patients with chronic HBV and HCV infections 60
Accuracy of the ElastPQ Technique for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C: a "Real Life" Single Center Study 60
Hepatitis C virus infection among institutionalized psychiatric patients: a regression analysis of indicators of risk. 59
Identification of an immunodominant B-cell epitope on the NS4 subregion of HCV defined by human monoclonal antibodies. 59
Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial. 59
Monitoring response to antiviral treatment by serum hepatitis C virus core antigen: too early to take shortcuts? 58
Is the natural history of hepatitis C virus carriers with normal aminotransferase really benign? 58
Association between class II allelles and protection or susceptibility to chronic hepatitis C 58
Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection 58
High efficiency of transmission of hepatitis C virus among babies born to human immunodeficiency virus-negative women. 58
HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy 58
Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs 58
Caratterizzazione delle IgG presenti nel crioprecipitato di pazienti con crioglobulinemia mista di tipo II associata ad infezione da HCV 58
Multifaceted functions of B cells in chronic hepatitis C virus infection 57
Comparative evaluation of two serologic typing methods of hepatitis C virus 57
HCV genotypes in the development of hepatocellular carcinoma (HCC) in anti-HCV positive cirrhotic patients: preliminary report of a prospective study 57
Natural killer cells in viral hepatitis: facts and controveries 57
A phase II, single arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 57
Comparative evaluation of two serological typing methods for hepatitis C virus 57
Mimotopes of the hypervariable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes. 56
Monoclonal antibodies defining the T-cell target antigens in acute and chronic HBV infection 56
Immunopathogenesis of viral hepatitis 56
Polymporphisms of P450 genes and risk of hepatocellular carcinoma in HCV-infected patients. 56
Totale 6.736
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.691
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020754 0 0 0 0 0 182 18 175 18 270 89 2
2020/20211.715 188 140 71 162 9 216 17 276 59 274 222 81
2021/20221.209 45 11 50 33 16 71 12 83 70 25 196 597
2022/20234.256 514 232 30 466 431 451 2 223 1.645 16 201 45
2023/20241.680 149 246 46 115 162 374 47 363 7 40 53 78
2024/2025953 90 395 136 162 61 109 0 0 0 0 0 0
Totale 15.447